Novaliq
Novaliq Inc.
Harvard Square
One Mifflin Place Suite 400
Cambridge, MA 02138
Phone: +49 6221 502590Website: https://www.novaliq.com/
Latest news
- FDA Approves Vevye (cyclosporine) Ophthalmic Solution for the Treatment of the Signs and Symptoms of Dry Eye Disease
8 June 2023 - Novaliq Announces Publication of Second Pivotal Phase 3 Trial Data on CyclASol® 0.1% (Cyclosporine Ophthalmic Solution) in JAMA Ophthalmology
12 April 2023 - Novaliq Announces FDA Acceptance of the New Drug Application for CyclaSol for the Treatment of Dry Eye Disease
24 October 2022
Drugs Associated with Novaliq Inc.
Novaliq Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Vevye
Generic name: cyclosporine Drug class: miscellaneous ophthalmic agents |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
